• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

Delcath Systems Inc

+ Add to Watchlist


2.0700 USD 0.0800 3.72%

As of 14:00:57 ET on 07/30/2014.

Snapshot for Delcath Systems Inc (DCTH)

Open: 2.1300 Day's Range: 2.0200 - 2.1600 Volume: 186,408
Previous Close: 2.1500 52wk Range: 2.0200 - 10.5600 1-Yr Rtn: -67.41%

Stock Chart for DCTH

No chart data available.
  • DCTH:US 2.0700
  • 1D
  • 1M
  • 1Y
Interactive DCTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DCTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.2100
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 19.31
Shares Outstanding (M) 9.44
30 Day Average Volume 72,023
Price/Book (mrq) 0.6585
Price/Sale (ttm) 23.1040
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DCTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DCTH

Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment.

Gabriel Leung "Gabe"ChairmanJennifer SimpsonInterim Co-Pres & Co- CEO/Exec VP
Graham G MiaoInterim Co-Pres & Co-CEO/CFOPeter James GrahamExec VP/Chief Compliance Ofcr
More Company Profile & Key Executives for DCTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil